Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice.

Postgraduate medical journal

Volumn 89, Issue 1052, 2013, Pages 346-351

  Sabir, Ian N ^a   Matthews, Gareth D K ^b   Huang, Christopher L H ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ATRIAL FIBRILLATION; DRUG ADMINISTRATION; DRUG INTERACTION; FEMALE; HUMAN; MALE; META ANALYSIS (TOPIC); PATHOPHYSIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; STROKE;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; STROKE; WARFARIN;

EID: 84891944988     PISSN: None     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-131386     Document Type: Review

References (0)